GMP Grade reagents for mRNA synthesis in therapeutics development and production
mRNA therapeutics have recently entered the limelight as new front in combating cancer, treating infections, and improving replacement therapies. The novelty of mRNAs as therapeutic agents entails uncertainties and new regulatory expectations as you transition from development through clinical manufacturing.
Choosing the right critical mRNA raw materials and the right supply partner is key to a seamless transition. Our commitment to next generation manufacturers and in support of the evolving market needs, Roche CustomBiotech’s fit-for-purpose mRNA raw materials reduce unnecessary uncertainties for your clinical development through commercial manufacturing.
Whether for development or large-scale mRNA production, our raw materials meet strict manufacturing and quality criteria, perform in narrow specifications and are delivered at the right scale across the globe.